3M: agreement for acquisition of Acelity
(CercleFinance.com) - The conglomerate 3M has announced an agreement to acquire Acelity and Its KCI subsidiaries worldwide from a consortium for a total enterprise value of approximately 6.
7 billion dollars, including net debt.
As a company operating in medical technology, Acelity focuses on major wound care and specialty surgical applications marketed under its KCI brand. The company's sales reached 1.5 billion dollars in 2018.
3M has warned that it now only expects to make further share repurchases of between 1 billion and 1.5 billion dollars in 2019, instead of between 2 billion and 4 billion dollars, due to this deal, which it expects to finalise in the second half of the year.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
7 billion dollars, including net debt.
As a company operating in medical technology, Acelity focuses on major wound care and specialty surgical applications marketed under its KCI brand. The company's sales reached 1.5 billion dollars in 2018.
3M has warned that it now only expects to make further share repurchases of between 1 billion and 1.5 billion dollars in 2019, instead of between 2 billion and 4 billion dollars, due to this deal, which it expects to finalise in the second half of the year.
Copyright (c) 2019 CercleFinance.com. All rights reserved.